VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017)
VitaNova Life Sciences (VNOV) posted Cash from Investing Activities of -$16538.0 for Q4 2017.
VitaNova Life Sciences (VNOV) Cash from Investing Activities (2017) Analysis & Trends
VitaNova Life Sciences' Cash from Investing Activities history runs 1 years deep, the most recent figure standing at -$16538.0 for Q4 2017.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$16538.0 in Q4 2017, while the trailing twelve-month figure through Jan 2020 was -$16538.0 (changed N/A YoY) and the FY2018 annual result came in at -$33914.0, changed N/A from the prior year.
- Cash from Investing Activities was -$16538.0 for Q4 2017 at VitaNova Life Sciences.
- Across five years, Cash from Investing Activities topped out at -$16538.0 in Q4 2017 and bottomed at -$16538.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 425.00 Mn |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | -4.87 Bn |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | -181.00 Mn |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | -63.00 Mn |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -3.21 Mn |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 53.93 Mn |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -754,000.00 |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | - |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -708,963.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2017 | -16,538.00 |
| Oct 31, 2017 | -16,538.00 |